Amyris To Acquire Assets of Menolabs Menopause Wellness Brand

Amyris, Inc. is acquiring the assets of MenoLabs, LLC, a women-founded company to that treats menopause symptoms. The acquisition fits into the Emeryville, CA-based company’s previously announced intent to launch a new consumer brand to provide science-backed, wellness and personal care products for this high-growth category.
 
The acquisition of MenoLabs will serve as a catalyst to accelerate growth and establish a leadership position in the fast-growing menopause market, said Amyris.

MenoLabs, a growing women's wellness brand is focused on addressing perimenopause and menopause symptoms. MenoLabs is one of few companies offering research-backed all-natural treatments of menopause symptoms; it has launched eight products, including MenoFit, an all-natural menopause relief supplement. MenoLabs generates a subscription-based, recurring revenue stream via its website and a subscribe and save option offered via the Amazon channel. The company is further expanding its omnichannel by penetrating retail channels in 2022.
 
Additionally, MenoLabs launched MenoLife, a perimenopause and menopause health tracker app which helps users track and analyze more than 40 menopause-related symptoms.
 
Menopause symptoms impact the lives of approximately 25 million women per year and 6,000 women in the US enter perimenopause every day (2.2 million each year). By 2025, there will be over one billion people experiencing menopause in the world or around 12% of the entire world population. The menopause market was valued at around $15 billion in 2020 and is expected to reach approximately $23 billion by 2028.
 
“We are very impressed with the MenoLabs offering which is synergistic with our science-based approach to real-world health and wellness issues. We are committed to empowering women and creating a platform to support them with our leading science and wellness technology platform. Women deserve products and solutions that work during this period in their lives,” said John Melo, president and CEO of Amyris. “Our acquisition of the products and app that the MenoLabs team has built accelerates Amyris' entry into the menopause market. We expect the combination of MenoLabs and the previously announced menopause brand with Naomi Watts to have the potential to deliver an estimated $30 million in revenue in their first year and expect significant growth potential in the years ahead.”